Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PGAM3P (phosphoglycerate mutase 3, pseudogene) is a processed pseudogene that resembles the functional phosphoglycerate mutase genes but is generally incapable of encoding an active protein due to disabling mutations[1][4][5]. Unlike true therapeutic targets, it does not participate directly in biochemical pathways and has no validated role in disease or pharmacology. While some pseudogenes can influence cellular function by regulatory RNA mechanisms (such as acting as microRNA sponges or undergoing DNA sequence exchange with a parent gene), PGAM3P itself is not documented to have any such recognized activity. The presence of PGAM3P—like many pseudogenes—mainly reflects genomic organization and evolution rather than functional significance for disease or drug targeting[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoglycerate mutase 3, pseudogene (PGAM3P).